Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART Trial: CRP-Guided Steroid Dosing in Pneumonia
NCT03852537Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2019
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in pneumonia, community acquired pneumonia (CAP), COVID-19 pneumonia, sponsored by Mayo Clinic. Started Dec 2019; status: completed.
02
Drugs
methylprednisolone
03
Conditions
pneumoniacommunity acquired pneumonia (CAP)COVID-19 pneumonia
Beyond the preview
Go deeper on NCT03852537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852537.